Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.
Vitruvian
Preventing Hernias Before They Happen

December 10, 2013
Mentor: Julie Cherrington
Team:
Cindy Chang, PhD
Hobart...
Preventing hernias before they happen.
Preventing hernias before they happen.
Preventing hernias before they happen.
Preventing hernias before they happen.
Preventing hernias before they happen.

Hernia (%)

100
80
60
40
20
0
saline

tissue sealant

low dose
MYOSEAL

high dose
...
Preventing hernias before they happen.
Business Model Canvas
Interviews

President of Paradigm Medical Consultants:
Medical insurers do want to keep cost down
but they have limited ab...
Interviews

Quotes from Surgeons

My patients don’t develop hernias after my
operations. The 10% incidence quoted in the
l...
Business Model Canvas

???
Interviews
Quote from Key Opinion Leader

With strong clinical data, I think most surgeons
would adopt hernia prevention. ...
Interview Partners
Partner Interviews
Myoseal Finance & Operations Timeline
Program
Pre-clinical
Formulation,
toxicology &
IND
enabling
studies

2014
1Q

2Q

20...
De-risk the Technology

Change to another
indication with the
same product

Alter the product
composition
Therapeutic Investment Readiness Level

Plausible exit
Cash to exit
Unit economics Validated
Reimbursement
Regulatory
Inte...
Therapeutic Investment Readiness Level Plausible
Therapeutic Investment Readiness Level Plausible
Therapeutic Investment Readiness Level Plausible
Therapeutic Investment Readiness Level Plausible
Therapeutic Investment Readiness Level Plausible
Therapeutic Investment Readiness Level Plausible
Therapeutic Investment Readiness Level Plausible
Nächste SlideShare
Wird geladen in …5
×

Therapeutic Investment Readiness Level Plausible Vitruvian week 10 presentation

80.307 Aufrufe

Veröffentlicht am

Therapeutic Investment Readiness Level

Plausible exit
Cash to exit
Unit economics Validated
Reimbursement
Regulatory
Intellectual Property
Attractive solution & ID of MVP
Compelling clinical need + large mkt
Effective team?

Veröffentlicht in: Bildung, Gesundheit & Medizin, Business
  • Als Erste(r) kommentieren

×